Blockchain and clinical trials

Clinical trials have evolved through a long and fascinating journey, withstanding a variety of challenges -ethical, scientific and regulatory. Over the years, as clinical trials have grown in sophistication and influence, they have, unsurprisingly, become encompassed in regulation as a result of the realisation by government authorities for the need for controlling medical therapies. And, as the advancement continues, new ethical and regulatory challenges requiring dynamic updates in the ethical and legal framework of clinical trials increase further. Recently, blockchain, with its inherent transparency, security and reliability, has emerged as one of the technologies that will douse the tension, meet the challenges and significantly change the sector. Many researchers are bullish about the growth of blockchain in healthcare, with a recent publication by Technavio predicting the global blockchain in healthcare market size would creep from $304.04million to $1.9billion between 2021 and…